Highlights for me:
- $2.25m cash NPAT after subtracting out non-cash items (notably, a once-off $5.68m non-cash expense for recognising the vendor share based payment for the RTO of Swift, which is due to the business being forecast to hit the performance milestones, which includes $29m revenue next year. This is GOOD)
- Gross profit improved from 32% FY17 to 42% FY18. Any further improvement in GP, combined with revenue growth, should see acceleration of EBITDA
- Free cashflow is very strong, allowing debt to be paid off entirely and ahead of schedule. No accounting games going on here, the cash doesn't lie
- Strong momentum in aged care, significant potential to expand offshore oil rig contracts.
- Implemented internal Netsuite ERP system, which is a gold-standard for globally growing businesses
- Going in to FY19 with solid recurring revenue base.
Overall it looks like FY19 is going to be a very solid year for SW1 and my modelling suggests that they will post a maiden NPAT for FY19 while having significant free cashflow to enable them to invest harder in to new opportunities.
- Forums
- ASX - By Stock
- Ann: Preliminary Final Report
Highlights for me:$2.25m cash NPAT after subtracting out...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SW1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
-0.002(16.7%) |
Mkt cap ! $9.810M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $10.15K | 1.000M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 830362 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 140143 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 199996 | 0.013 |
2 | 691666 | 0.012 |
1 | 226370 | 0.011 |
1 | 100000 | 0.010 |
1 | 120000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 531250 | 1 |
0.018 | 462860 | 1 |
0.019 | 1000000 | 1 |
0.020 | 218562 | 1 |
0.021 | 70000 | 1 |
Last trade - 15.48pm 25/11/2024 (20 minute delay) ? |
Featured News
SW1 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online